More than 80% of HHT patients carry a sequence variation in endoglin or ALK-1 [31], most (but not all [32,33]) disease-causing, whilst 1-2% carry a mutation in SMAD4 [34]. The gene discussed is SMAD4; the disease is hereditary hemorrhagic telangiectasia.